Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4105257 | 0.88 | ALDH1A1 (0.38) | ALDH1A1TDP1 | |
| SCHEMBL4083765 | 0.84 | TDP1 (0.52) | TDP1 | |
| SCHEMBL182417 | 0.79 | LMNA (0.35) | ALDH1A1TDP1 | |
| SCHEMBL7153740 | 0.79 | — | — | |
| SCHEMBL4291612 | 0.79 | — | — | |
| SCHEMBL819583 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TDP1 | |
| SCHEMBL5581614 | 0.75 | — | — | |
| SCHEMBL7520510 | 0.75 | — | — | |
| SCHEMBL29054510 | 0.75 | TSHR (0.33) | ALDH1A1 | |
| Oxirane SCHEMBL2544975 | 0.74 | LMNA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206939-A1 | CURABLE SULFONATED POLYMER COMPOSITIONS | NOTARK CORPORATION (US) | 2025-06-26 | — | — | US | claimed |
| CN-116211887-A | Composition for treating acid-base imbalance | 特里赛达公司 | 2023-06-06 | — | — | CN | claimed |
| US-11634556-B2 | Method for preparing accelerator for sprayed mortar/concrete | JIANGSU ARIT NEW MATERIALS CO., LTD. (CN) | 2023-04-25 | — | — | US | claimed |
| US-20230069580-A1 | CHEMICALLY CROSS-LINKED HYDROGEL AND ITS MICROSPHERES, PREPARATION METHOD AND APPLICATION | Zhongxin Biotechnology (Zhejiang) Co., Ltd. (CN) | 2023-03-02 | — | — | US | claimed |
| US-20220169826-A1 | METHOD FOR PREPARING ACCELERATOR FOR SPRAYED MORTAR/CONCRETE | JIANGSU ARIT NEW MATERIALS CO.,LTD. (CN) | 2022-06-02 | — | — | US | claimed |
| US-11267924-B2 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | GENZYME CORPORATION (US) | 2022-03-08 | — | — | US | claimed |
| US-11197887-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2021-12-14 | — | — | US | claimed |
| EP-3593808-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2020-12-09 | — | — | EP | claimed |
| EP-3578185-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2020-08-05 | — | — | EP | claimed |
| CN-106102777-B | Novel sugar alcohol-based compositions for in vivo and in vitro delivery of nucleic acid-based drugs | 林希龙 | 2019-12-17 | — | — | CN | claimed |
| EP-1540325-B1 | COATED CAPILLARY ELECTROPHORESIS TUBES AND SYSTEM | BECKMAN COULTER INC (US) | 2010-03-03 | — | — | EP | claimed |
| US-20080085259-A1 | Amine condensation polymers as phosphate sequestrants | GENZYME CORPORATION | 2008-04-10 | — | — | US | claimed |
| EP-1540325-A4 | COATED CAPILLARY ELECTROPHORESIS TUBES AND SYSTEM | BECKMAN COULTER INC (US) | 2007-09-26 | — | — | EP | claimed |
| WO-2006134299-A1 | METHOD FOR MAKING A GEL-TYPE COMPOUND, FOR TREATING EFFLUENT | UNIVERSITE DE FRANCHE-COMTE (FR) | 2006-12-21 | — | — | WO | claimed |
| US-20050224356-A1 | Coated capillary electrophoresis tubes and system | RATNAYAKE CHITRA K | 2005-10-13 | — | — | US | claimed |
| US-6923895-B2 | Coated capillary electrophoresis tubes and system | BECKMAN COULTER, INC. (US) | 2005-08-02 | — | — | US | claimed |
| EP-1540325-A2 | COATED CAPILLARY ELECTROPHORESIS TUBES AND SYSTEM | Beckman Coulter, Inc. (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004023104-A2 | COATED CAPILLARY ELECTROPHORESIS TUBES AND SYSTEM | BECKMAN COULTER, INC. (US) | 2004-03-18 | — | — | WO | claimed |
| US-20040045828-A1 | Coated capillary electrophoresis tubes and system | BECKMAN COULTER, INC. | 2004-03-11 | — | — | US | claimed |
| WO-1991019675-A1 | METHOD AND DEVICE FOR PURIFYING WATER | RICOH KYOSAN, INC. (JP) | 1991-12-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11267924-B2 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | IAPP, PARP2, ADM2 | ALDH1A1 3896/4885TDP1 2564/4885 |
| US-20080085259-A1 | Amine condensation polymers as phosphate sequestrants | PHPT1, CEPT1, PNMT | ALDH1A1 3709/4885TDP1 1167/4885 |
| US-11197887-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885TDP1 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.